• 1
    Neuschwander-Tetri B, Caldwell S. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 120219.
  • 2
    Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party. Hepatology 1998; 27: 14636.
  • 3
    Lettéron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24: 2008.
  • 4
    Berson A, De Beco V, Lettéron P, et al. Steatohepatitis-induced drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 76474.
  • 5
    Grattagliano I, Vendemiale G, Caraceni P, et al. Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. J Nutr 2000; 130: 21316.
  • 6
    Oliveira CPMS, da Costa Gayotto LC, Lima ES, et al. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med 2002; 6: 399406.
  • 7
    Yang SQ, Lin HZ, Lane MD, Clemens M, Dieh AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94: 255762.
  • 8
    Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis. Hepatology 1998; 27: 12833.
  • 9
    Sanyal AR, Campbell-Sargent C, Mirshani F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 118392.
  • 10
    Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med 1999; 27: 128491.
  • 11
    De Maria N, Colantoni A, Fagiuoli S, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radical Biol Med 1996; 21: 2915.
  • 12
    Chrobot AM, Szaflarska-Szizepanlk A, Drew AG. Antioxidant defense in children with viral hepatitis B and C. Med Sci Monit 2000; 6: 7138.
  • 13
    Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with non-alcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1497502.
    Direct Link:
  • 14
    Yesilova Z, Yaman H, Oktenli C, et al. Systemic markers of lipid peroxidation and antioxidants in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 8505.
    Direct Link:
  • 15
    Day CP, James OF. Steatohepatitis: a tale of two ‘hits’? Gastroenterology 1998; 114: 8425.
  • 16
    Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 28993.
  • 17
    Brunt EM, Janney CG, DiBisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 246774.
    Direct Link:
  • 18
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 19
    Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 2126.
  • 20
    Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high performance liquid chromatography. J Chromatogr 1991; 572: 1036.
  • 21
    Clavel JP, Chalvignac B, Thuillier A. Dosage du sélénium dans les liquides biologiques par spectrométrie d'absorption atomique électrothermique. J Pharmacol Clin 1983; 2: 5564.
  • 22
    De Haan JB, Newman JD, Kola I. Cu/Zn superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Molec Brain Res 1992; 13: 17987.
  • 23
    Paglia DE, Valentine WN. Studies of the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 15869.
  • 24
    Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J Hepatol 2002; 37: 5662.
  • 25
    Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol 2005; 42: 58591.
  • 26
    Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stelate cells by cytochrom P450 2E1-derived reactive oxygen species. Hepatology 2002; 35: 6273.
  • 27
    Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with non-alcoholic steatohepatitis. Ann Clin Lab Sci 2004; 34: 5762.
  • 28
    Yang SQ, Zhu H, Li Y, Gabrielson K, Trush MA, Diehl AM. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000; 378: 25968.
  • 29
    Halliwell B, Gutteridge JMC. Free radicals in Biology and Medicine, 3rd edn. Oxford: Oxford Univ Press, 1999.
  • 30
    Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimen. Hum Pathol 2004; 35: 107082.
  • 31
    Ramesh S, Sanyal AJ. Hepatitis C and non-alcoholic fatty liver disease. Semin Liver Dis 2004; 24: 399413.
  • 32
    Hezode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat 2004; 11: 4558.